Search alternatives:
point decrease » point increase (Expand Search)
teer decrease » greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
teer decrease » greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
20121
DataSheet1_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.pdf
Published 2023“…<p>As effective therapies for relapse and refractory B-cell acute lymphoblastic leukemia (B-ALL) remain problematic, novel therapeutic strategies are needed. Artemis is a key endonuclease in V(D)J recombination and nonhomologous end joining (NHEJ) of DNA double-strand break (DSB) repair. …”
-
20122
DataSheet1_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.docx
Published 2023“…<p>As effective therapies for relapse and refractory B-cell acute lymphoblastic leukemia (B-ALL) remain problematic, novel therapeutic strategies are needed. Artemis is a key endonuclease in V(D)J recombination and nonhomologous end joining (NHEJ) of DNA double-strand break (DSB) repair. …”
-
20123
-
20124
Glycochenodexycholic (GCDCA) causes lumen obstruction and subepithelial fibrosis of neonatal extrahepatic bile ducts (EHBDs), while ursodeoxycholic acid (UDCA) attenuates GCDCA tox...
Published 2022“…<p>(a) Neonatal EHBD were dissected and incubated for 24 hours in biliary epithelial cell media, with or without GCDCA 5mM, and with GCDCA 5mM combined with UDCA acid 5mM. …”
-
20125
Microglia-plaque dynamics measured in the hippocampus of p38<sup>+/+</sup> and p38<sup>KO</sup> AD mice.
Published 2023“…<p>(A) Left panels: Representative images of tissue sections probed for microglia (Iba1: TxRed [red]), fibrillar amyloid deposits (Thioflavin S: FITC [green]), and Aβ peptides (6E10: Cy5 [purple]) obtained on a Nikon confocal microscope. …”
-
20126
-
20127
-
20128
Internet-Delivered Cognitive Behavioral Therapy to Treat Insomnia: A Systematic Review and Meta-Analysis
Published 2016“…Internet-delivered cognitive behavioral therapy resulted in a decrease in the insomnia severity index by 4.3 points (95% CI: -7.1, -1.5; p = 0.017) compared to control. …”
-
20129
-
20130
-
20131
-
20132
Data_Sheet_1_Effects of Aberrant miR-384-5p Expression on Learning and Memory in a Rat Model of Attention Deficit Hyperactivity Disorder.pdf
Published 2020“…This study investigated the effects of aberrant miR-384-5p expression on learning and memory in a widely used ADHD rat model. …”
-
20133
Table5_Efficacy and safety of fenofibrate add-on therapy in patients with primary biliary cholangitis refractory to ursodeoxycholic acid: A retrospective study and updated meta-ana...
Published 2022“…</p><p>Results: Our meta-analysis included nine publications with a total of 389 patients, including 216 treated with UDCA alone and 173 who received combination therapy. …”
-
20134
-
20135
-
20136
-
20137
-
20138
DataSheet1_Characterization of the PM2.5 aerosol fraction monitored at a suburban site in south-eastern Italy by integrating isotopic techniques and ion beam analysis.docx
Published 2022“…The concentrations of these elements showed a significant decrease during the weekend, mostly in the case of elements of anthropogenic origin, according to the data on the PM2.5 temporal evolution. …”
-
20139
<i>In Vivo</i> Voltage-Sensitive Dye Study of Lateral Spreading of Cortical Activity in Mouse Primary Visual Cortex Induced by a Current Impulse
Published 2015“…We used in vivo RH1691 voltage-sensitive dye (VSD) imaging and intracortical microstimulation in adult C57BL/6 mice to elucidate the spatiotemporal properties of population-level signal spreading in V1 cortical circuits. The evoked response was qualitatively similar to that measured in single-cell electrophysiological experiments in rodents: a fast transient fluorescence peak followed by a fast and a slow decrease or hyperpolarization, similar to EPSP and fast and slow IPSPs in single cells. …”
-
20140
Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study
Published 2016“…Everolimus was initiated at a dose (4.5 mg/m<sup>2</sup>/day) titrated to a target blood trough of 5–15 ng/mL. …”